Byotrol PLC Result of AGM (3556M)
September 13 2023 - 10:33AM
UK Regulatory
TIDMBYOT
RNS Number : 3556M
Byotrol PLC
13 September 2023
Byotrol plc
("Byotrol" or the "Company")
Result of Annual General Meeting ("AGM")
Byotrol plc (AIM: BYOT), the developer of anti-microbial hygiene
technologies, announces that all resolutions proposed at the AGM
held earlier today, as set out in the Notice of Annual General
Meeting, were duly passed.
The total proxy votes cast prior to the AGM were as follows:
Resolution In favour Discretion Against Withheld
*
Votes % Votes % Votes % Votes
1 66,180,547 99.96% 1,500 0.01% 20,431 0.03% 1,339,665
2 64,703,257 95.88% 2,783,623 4.12% 55,263
3 64,681,263 95.84% 2,805,617 4.16% 55,263
4 66,189,047 98.11% 1,273,033 1.89% 80,063
5 65,854,428 97.57% 1,638,901 2.43% 48,814
6 64,561,174 95.66% 2,932,155 4.34% 48,814
7 66,077,089 97.90% 1,419,791 2.10% 45,263
*A vote withheld is not a vote in law and is therefore not
counted towards the proportion of votes "in favour" or "against"
the resolutions.
Change of Name of Nominated Adviser and Broker
The Company also announces that its Nominated Adviser and Sole
Broker has changed its name to Cavendish Capital Markets Limited
following completion of its own corporate merger.
Enquiries:
Byotrol Plc
Trevor Francis - Chairman
Vivan Pinto - Chief Executive Officer +44 (0)1925 742 000
Chris Sedwell - Chief Financial Officer
Cavendish Capital Markets Limited (Nominated
Adviser and Broker) +44 (0)20 7220 0500
Geoff Nash / George Dollemore - Corporate
Finance
Nigel Birks / Harriet Ward - ECM
Flagstaff Strategic and Investor Communications +44 (0)20 7129 1474
Tim Thompson/Andrea Seymour/Fergus Mellon byotrol@flagstaffcomms.com
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the
Healthcare, Industrial, Food and Consumer sectors, providing low
toxicity products with a broad-based and targeted efficacy across
all microbial classes; bacteria, viruses (including coronavirus),
fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, go to byotrol.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGFLFVSAIIVLIV
(END) Dow Jones Newswires
September 13, 2023 10:33 ET (14:33 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Byotrol (LSE:BYOT)
Historical Stock Chart
From Jan 2024 to Jan 2025